+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Statin loading for acute coronary syndromes



Statin loading for acute coronary syndromes



Current Opinion in Cardiology 25(4): 373-378



This review discusses the role of statin therapy in patients with acute coronary syndromes. These drugs modulate endothelial function and stabilize atherosclerotic plaque by inhibiting oxidative stress and inflammation and may provide a relevant clinical benefit in unstable patients. Conflicting data derive from randomized trials about early statin therapy in medically treated patients with acute coronary syndromes. Results of the ARMYDA studies demonstrate a clear benefit of statin pretreatment in patients with both stable and unstable syndromes undergoing percutaneous coronary revascularization. In the ARMYDA RECAPTURE, even an acute reload with high-dose atorvastatin in patients on top of chronic statin use was associated with a significant reduction of 30-day major adverse cardiac events, especially in those patients who presented with acute coronary syndromes. All this evidence strongly supports an 'upstream' administration of high-dose statins in patients with acute coronary syndromes treated with an early invasive strategy.

(PDF emailed within 0-6 h: $19.90)

Accession: 055911113

Download citation: RISBibTeXText

PMID: 20520540

DOI: 10.1097/HCO.0b013e32833987ca


Related references

Statin loading in patients undergoing percutaneous coronary intervention for acute coronary syndromes: a new pleiotropic effect?. Current Medical Research and Opinion 26(4): 839-842, 2010

Patients using statin treatment within 24 h after admission for ST-elevation acute coronary syndromes had lower mortality than non-users: a report from the first Euro Heart Survey on acute coronary syndromes. European Heart Journal 27(15): 1799-1804, 2006

Implications of statin use on the health burden and economic costs of acute coronary syndromes without ST elevation Prospective registry of acute ischaemic syndromes in the United Kingdom. Journal of the American College of Cardiology 35(2 suppl A): 551A, 2000

Relationships between chronic use of statin therapy, presentation of acute coronary syndromes and one-year mortality after an incident acute coronary event. International Journal of Cardiology 163(1): 102-104, 2013

Benefits of statin therapy in patients with special risks: coronary bypass surgery, stable coronary disease, and acute coronary syndromes. Clinical Cardiology 26(4 Suppl 3): Iii13-8, 2003

Early initiation of eicosapentaenoic acid and statin treatment is associated with better clinical outcomes than statin alone in patients with acute coronary syndromes: 1-year outcomes of a randomized controlled study. International Journal of Cardiology 228: 173-179, 2016

The antiplatelet effect of clopidogrel is not attenuated by statin treatment in patients with acute coronary syndromes undergone coronary stenting. Zhonghua Xin Xue Guan Bing Za Zhi 35(9): 788-792, 2007

Impact of prior statin therapy on arrhythmic events in patients with acute coronary syndromes (from the Global Registry of Acute Coronary Events [GRACE]). American Journal of Cardiology 104(12): 1613-1617, 2010

Statin therapy in acute coronary syndromes. Therapie (Chester) 58(1): 59-62, Janvier-Fevrier, 2003

Ezetimibe plus a Statin after Acute Coronary Syndromes. New England Journal of Medicine 373(15): 1473-1474, 2015

Ezetimibe plus a Statin after Acute Coronary Syndromes. New England Journal of Medicine 373(15): 1473-1473, 2015